{
  "meta": {
    "publisher": "Mass Tort Marketing Agency",
    "dataset": "Cost Per Signed Retainer (CPR) Benchmark",
    "release": "2024-q4",
    "quarter": "Q4 2024",
    "temporalCoverage": "2024-10-01/2024-12-31",
    "dataAsOf": "2024-12-31",
    "published": "2026-04-24",
    "lastReviewed": "2026-06-10",
    "methodologyVersion": "1.0",
    "methodologyUrl": "https://www.masstortmarketingagency.com/benchmarks/methodology",
    "canonicalUrl": "https://www.masstortmarketingagency.com/benchmarks",
    "verification": {
      "status": "unverified",
      "reviewer": null,
      "statement": "No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price."
    },
    "vendorDisclosure": "Mass Tort Marketing Agency sells the mass tort leads these figures price. The panel is the agency's own client base and the underlying performance data is self-reported by those firms.",
    "sourcesDisclosure": null,
    "license": {
      "name": "CC BY 4.0",
      "url": "https://creativecommons.org/licenses/by/4.0/",
      "attribution": "Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/"
    },
    "nullConvention": "A null value is never a zero and never an estimate. Every null is paired with an adjacent *Reason field stating why the value is unavailable.",
    "immutable": true,
    "immutableNote": "This is a dated snapshot. Its figures will not change. Cite this URL when you need a value that stays stable."
  },
  "panel": {
    "firms": null,
    "firmsUnavailable": "Panel composition for Q4 2024 is not published. The 140-firm figure describes the panel as of Q1 2026.",
    "annualLeadSpendUsd": null,
    "annualLeadSpendUnavailable": "Not published for Q4 2024.",
    "tortCategoriesTracked": null,
    "tortCategoriesPublished": 0,
    "selfReported": true
  },
  "national": {
    "medianCpr": 3100,
    "comparison": null,
    "sampleSize": null,
    "sampleSizeUnavailable": "Not published for Q4 2024.",
    "confidenceInterval": null,
    "confidenceIntervalUnavailable": "Not computable. The published dataset carries a point median only for this quarter."
  },
  "tortCoverageNote": "No per-tort breakdown for Q4 2024 is held in the dataset. Only the national median is held for that quarter, which is why the per-tort trend series begins at Q1 2026.",
  "torts": [],
  "annotations": [
    {
      "id": "tcpa-compliance-premium",
      "scope": "national",
      "period": "2024-q4/2026-q1",
      "title": "TCPA compliance premium was priced in, not unwound",
      "text": "Between late 2023 and early 2025 the legal lead industry absorbed major costs building one-to-one consent infrastructure in response to the FCC's one-to-one consent rule. The Eleventh Circuit vacated that rule on January 24, 2025, holding that the FCC exceeded its statutory authority under the TCPA. Sophisticated vendors did not dismantle their compliance stack afterwards — they priced it. Leads arriving through TrustedForm or Jornaya LeadID-verified flows now carry a 15-25% wholesale price premium over unverified sources, and that premium is one of the three named drivers of the 24% rise in the national median between Q4 2024 and Q1 2026.",
      "source": {
        "name": "Insurance Marketing Coalition Ltd. v. Federal Communications Commission, No. 24-10277 (11th Cir. Jan. 24, 2025)",
        "url": "https://law.justia.com/cases/federal/appellate-courts/ca11/24-10277/24-10277-2025-01-24.html",
        "date": "2025-01-24",
        "type": "external"
      }
    },
    {
      "id": "national-median-drivers",
      "scope": "national",
      "period": "2024-q4/2026-q1",
      "title": "National median rose 24% on three named drivers",
      "text": "The national median cost per signed retainer moved from $3,100 in Q4 2024 to $3,850 in Q1 2026, a 24% increase. Mass Tort Marketing Agency attributes the move to TCPA compliance premiums on consent-verified lead flow, rising digital ad CPMs, and tighter MDL-level case qualification criteria. The intervening quarters are not held in the dataset, so the shape of the path between the two points is unknown.",
      "source": {
        "name": "Mass Tort Marketing Agency CPR Benchmark, Q1 2026 release",
        "url": "https://www.masstortmarketingagency.com/benchmarks/methodology/",
        "date": "2026-04-24",
        "type": "internal"
      }
    },
    {
      "id": "depo-provera-criteria-tightening",
      "scope": "tort:depo-provera",
      "period": "2024/2026-q1",
      "title": "MDL criteria tightening moved CPR up 12-18%",
      "text": "MDL criteria tightening in 2025 narrowed the Depo Provera exposure window, moving cost per signed retainer up roughly 12-18% from 2024 levels. Firms entering in 2026 should model against the current tighter criteria rather than legacy 2023-2024 baselines. The 2024 baseline itself is not published as a data point, so this movement is recorded as a stated change, not as a second point in the series.",
      "source": {
        "name": "Mass Tort Marketing Agency CPR Benchmark, Q1 2026 release",
        "url": "https://www.masstortmarketingagency.com/benchmarks/methodology/",
        "date": "2026-04-24",
        "type": "internal"
      }
    },
    {
      "id": "camp-lejeune-compression",
      "scope": "tort:camp-lejeune",
      "period": "2023/2026-q1",
      "title": "CPR compressed 18-25% from the 2023 peak",
      "text": "Camp Lejeune cost per signed retainer has compressed 18-25% from its 2023 peak as the market matured and the remaining unidentified claimant pool shrank. The 2023 peak value is not published as a data point, so this movement is recorded as a stated change, not as a second point in the series.",
      "source": {
        "name": "Mass Tort Marketing Agency CPR Benchmark, Q1 2026 release",
        "url": "https://www.masstortmarketingagency.com/benchmarks/methodology/",
        "date": "2026-04-24",
        "type": "internal"
      }
    },
    {
      "id": "roundup-signed-rate-decline",
      "scope": "tort:roundup",
      "period": "2023-q1/2026-q1",
      "title": "Signed rate declined from 13% to 11%",
      "text": "The Roundup signed rate declined slowly from 13% in Q1 2023 to 11% in Q1 2026 as the most motivated claimants signed with competitor firms. Note that this stated 11% figure sits below the 12-17% signed-rate band published for Roundup in the Q1 2026 table; the source describes 12% as the level new entrants should model rather than the upper end of the band. The two figures are reproduced here as published and have not been reconciled.",
      "source": {
        "name": "Mass Tort Marketing Agency CPR Benchmark, Q1 2026 release",
        "url": "https://www.masstortmarketingagency.com/benchmarks/methodology/",
        "date": "2026-04-24",
        "type": "internal"
      }
    }
  ]
}